NIH Funding Opportunities
Notice of Change in Eligibility for PAR-16-406 "Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project (U01)"
Notice NOT-AG-16-034 from the NIH Guide for Grants and Contracts
Wed, 24 Aug 2016 12:04:37 EST
Notice of Pre-application Webinar for PAR-16-105 "Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01)"
Notice NOT-CA-16-066 from the NIH Guide for Grants and Contracts
Wed, 24 Aug 2016 10:58:41 EST
Request for Information: Epidemiology Research on Novel Infectious Agents and Cancer Occurrence and Outcomes
Notice NOT-CA-16-067 from the NIH Guide for Grants and Contracts
Fri, 26 Aug 2016 09:53:49 EST
Notice of Correction to Key Dates for RFA-DK-16-512 "Limited Competition for the Continuation of the Hepatitis B Research Network Clinical Centers (U01)"
Notice NOT-DK-16-027 from the NIH Guide for Grants and Contracts
Fri, 26 Aug 2016 10:24:25 EST
Notice of Pre-application Webinars for the Kidney Precision Medicine Project: "RFA-DK-16-026 - Recruitment Sites (UG3/UH3), RFA-DK-16-027 - Tissue Interrogation Sites (UG3/UH3) and RFA-DK-16-028 - Central Hub (U2C)
Notice NOT-DK-16-028 from the NIH Guide for Grants and Contracts
Wed, 24 Aug 2016 12:18:42 EST
Notice of Participation of NIGMS in RFA-MD-16-002 "NIH Big Data to Knowledge (BD2K) Enhancing Diversity in Biomedical Data Science (R25)"
Notice NOT-GM-16-112 from the NIH Guide for Grants and Contracts
Thu, 25 Aug 2016 11:37:44 EST
Notice of Participation of NIGMS in RFA-LM-17-001 "NIH Big Data to Knowledge (BD2K) Enhancing the Efficiency and Effectiveness of Digital Curation for Biomedical Big Data (U01)"
Notice NOT-GM-16-116 from the NIH Guide for Grants and Contracts
Fri, 26 Aug 2016 10:00:05 EST
Notice of Correction to PAR-16-345 "Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25)"
Notice NOT-HG-16-025 from the NIH Guide for Grants and Contracts
Wed, 24 Aug 2016 10:42:29 EST
New NHLBI Policy: Investigator-Initiated Single-Site Clinical Trials (Phase II and beyond)
Notice NOT-HL-16-336 from the NIH Guide for Grants and Contracts
Thu, 25 Aug 2016 12:11:04 EST
Notice of NINR's Participation in RFA-LM-17-001 "Big Data to Knowledge (BD2K) Enhancing the Efficiency and Effectiveness of Digital Curation for Biomedical Big Data (U01)"
Notice NOT-NR-16-005 from the NIH Guide for Grants and Contracts
Wed, 24 Aug 2016 12:36:01 EST
Notice to Participate in RFA-ES-16-011 "BD2K Research Education Curriculum Development: Data Science Overview for Biomedical Scientists (R25)"
Notice NOT-NR-16-007 from the NIH Guide for Grants and Contracts
Wed, 24 Aug 2016 10:51:03 EST
Revision: Extramural Loan Repayment Program for Clinical Researchers (LRP-CR)
Notice NOT-OD-16-138 from the NIH Guide for Grants and Contracts
Wed, 24 Aug 2016 02:32:12 EST
Revision: Extramural Loan Repayment Program for Pediatric Research (LRP-PR)
Notice NOT-OD-16-139 from the NIH Guide for Grants and Contracts
Wed, 24 Aug 2016 02:41:51 EST
Revision: Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)
Notice NOT-OD-16-140 from the NIH Guide for Grants and Contracts
Wed, 24 Aug 2016 04:15:36 EST
Revision: Extramural Loan Repayment Program for Health Disparities Research (LRP-HDR)
Notice NOT-OD-16-141 from the NIH Guide for Grants and Contracts
Thu, 25 Aug 2016 08:32:23 EST
Revision: Extramural Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds (LRP-IDB)
Notice NOT-OD-16-142 from the NIH Guide for Grants and Contracts
Thu, 25 Aug 2016 08:25:44 EST
Notice of Change to the Eligible Activity Codes for PA-16-334 "Science of Behavior Change: Use-inspired Basic Research to Optimize Behavior Change Interventions and Outcomes (Admin Supp)"
Notice NOT-RM-16-026 from the NIH Guide for Grants and Contracts
Wed, 24 Aug 2016 12:09:50 EST
Big Data to Knowledge (BD2K) Enhancing the Efficiency and Effectiveness of Digital Curation for Biomedical Big Data (U01)
Funding Opportunity RFA-LM-17-001 from the NIH Guide for Grants and Contracts. The purpose of this BD2K Funding Opportunity Announcement (FOA) is to support the development, improvement and implementation of tools and approaches that increase the efficiency and effectiveness of digital curation processes used to characterize and describe the digital data used in or resulting from biomedical research.
Wed, 24 Aug 2016 11:59:23 EST
BRAIN Initiative: Non-Invasive Neuromodulation - New Tools and Techniques for Spatiotemporal Precision (R01)
Funding Opportunity RFA-MH-17-240 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications in two related but distinct areas. The first area is in the development and testing of novel tools and methods of neuromodulation that go beyond the existing variations on magnetic or electrical stimulation, and that represent more than an incremental advance over existing approaches. The second distinct area that this FOA seeks to encourage is the optimization of existing electrical and magnetic stimulation methods.
Tue, 23 Aug 2016 11:55:36 EST
BRAIN Initiative: Non-Invasive Neuromodulation - Mechanisms and Dose/Response Relationships for Targeted CNS Effects (R01)
Funding Opportunity RFA-MH-17-245 from the NIH Guide for Grants and Contracts. The focus of this Funding Opportunity Announcement (FOA) is to better understand how existing non-invasive neuromodulation devices affect brain circuity. This information should shed light on dose/response relationships that could be used for neuroscience applications and clinical interventions.
Tue, 23 Aug 2016 11:55:41 EST
NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)
Funding Opportunity RFA-NS-17-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for the Morris K. Udall Centers of Excellence for Parkinsons Disease Research program. The overarching goal of the specialized Udall Centers program is to establish a network of Centers that work collaboratively as well as independently to define the causes of and discover improved treatments for Parkinsons disease (PD). A more immediate goal for each Center is to rapidly advance synergistic, interdisciplinary research programs while serving as national leaders in PD research. Udall Centers also serve as local resources by organizing research career enhancement activities for Center investigators and periodic outreach to the PD patient/advocacy community. Applicants are expected to identify and address an overall research theme that defines a critical challenge in PD research. The stated theme, proposed research projects, and associated cores will inform the etiology, pathogenesis or treatment of PD; investigations on related synucleinopathies may be included if such studies directly address the identified PD research challenge. Requirements include 1) a minimum of three research projects; 2) research cores that are each essential to accomplish the aims of at least two proposed research projects, plus an Administrative Core; 3) a mission statement and plan for career enhancement of Center researchers; and 4) a plan for effective outreach to the local patient community. The NINDS Udall Centers program prioritizes innovative and integrative research with significant potential for discovery. A considerable degree of synergy must be evident among Center research projects and cores, such that successful completion of the aims could not be accomplished without the Center structure. The Udall Center Director (PD/PI) must be an established leader in scientific research with visionary leadership skills and proven expertise in the stewardship of large-scale research programs. Eligible institutions must demonstrate commitment to and support for the establishment and/or continuation of the proposed Udall Center. Funding decisions will focus on those applications most likely to make significant contributions to PD research, as well as those with greatest potential to collaborate effectively across the Centers program.
Thu, 25 Aug 2016 11:30:03 EST
Bench Testing Therapeutic/Indication Pairing Strategies (UH2/UH3)
Funding Opportunity RFA-TR-16-015 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications for support of pre-clinical studies to repurpose existing drugs or biologics (therapeutics) that have already begun or completed at least a Phase l trial. The hypothesis for proposed studies must be developed using innovative processes to identify the therapeutic/indication pair. Examples include independent crowdsourcing strategies (e.g., http://www.ncats.nih.gov/ntu/assets/current, http://openinnovation.astrazeneca.com/, or any website that lists experimental therapies), computational algorithms, or use of big datasets from several million patient records (e.g., electronic health records, pharmacy datasets, or insurance records).
Thu, 25 Aug 2016 11:57:37 EST
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Phase I Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grantees (Admin Supp )
Funding Opportunity PA-16-414 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) seeks to develop and nurture a national innovation ecosystem that builds upon biomedical research to develop technologies, products and services that benefit society. Toward meeting this objective, the I- Corps program is being offered. The I-Corps at NIH program is focused on educating researchers and technologists on how to translate technologies from the lab into the marketplace. Under this FOA, participating NIH and CDC Institutes and Centers will provide administrative supplement awards to two cohorts of currently-funded SBIR and STTR Phase I grantees to support entrepreneurial training under the I-Corps at NIH Program. The program is designed to provide three-member project teams with access to instruction and mentoring in order to accelerate the translation of technologies currently being developed with NIH and CDC SBIR and STTR funding. It is anticipated that outcomes for the I-Corps teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies. Prospective applicants are strongly encouraged to contact NIH or CDC Scientific/Research staff for more information about the program before applying.
Thu, 25 Aug 2016 10:42:32 EST
Centers of Biomedical Research Excellence (COBRE) (P20)
Funding Opportunity PAR-16-415 from the NIH Guide for Grants and Contracts. The National Institute of General Medical Sciences (NIGMS) invites applications for Centers of Biomedical Research Excellence (COBRE) from investigators at biomedical research institutions that award doctoral degrees in the health sciences or sciences related to health or at independent biomedical research institutes with ongoing biomedical research programs funded by the NIH or other federal agencies within Institutional Development Award (IDeA) eligible states. The objectives of the COBRE initiative is to strengthen an institution's biomedical research infrastructure through the establishment of a thematic multi-disciplinary center and to enhance the ability of investigators to compete independently for complementary National Institutes of Health (NIH) individual research grants or other external peer-reviewed support. COBRE awards are supported through the IDeA Program, which aims to foster health-related research by increasing the competitiveness of investigators at institutions located in states with historically low aggregate success rates for grant awards from the NIH.
Thu, 25 Aug 2016 02:33:08 EST
NCI Small Grants Program for Cancer Research (NCI Omnibus R03)
Funding Opportunity PAR-16-416 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
Fri, 26 Aug 2016 08:27:50 EST
NLM Grants for Scholarly Works in Biomedicine and Health (G13)
Funding Opportunity PAR-16-417 from the NIH Guide for Grants and Contracts. NLM Grants for Scholarly Works in Biomedicine and Health are awarded for the preparation of book-length manuscripts and other works of academic and/or public health policy value to U.S. health professionals, public health officials, biomedical researchers and historians of the health sciences.
Fri, 26 Aug 2016 11:02:22 EST